Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study suggests HPV16 can skirt the immune system

16.07.2003


Human papillomavirus 16 (HPV16), the virus responsible for approximately half of all cervical cancers, appears to be better at dodging the immune system than other HPV types, according to a large study of HIV-positive women in the July 16 issue of the Journal of the National Cancer Institute. The findings may help explain why HPV16 plays such a major role in causing cervical cancer in the general population.

Whereas other HPV types have a lower prevalence and incidence among women with stronger immune systems (in theory, the stronger the immune system, the better it is at fighting off infections), researchers detected similar levels of HPV16 in women with both weak and strong immune systems.

More than 30 types of HPV are known to infect the genital epithelium. HPV16 has been the strain most strongly associated with cervical cancer and its precursor lesions. What sets HPV16 apart from other HPV types has not been clear. A preliminary analysis of a study on HPV infection among women positive for HIV, the virus that causes AIDS, suggested that HPV16 may be less associated with immune status than other HPV types.



To confirm this theory, Howard D. Strickler, M.D., and Robert D. Burk, M.D., of the Albert Einstein College of Medicine in Bronx, N.Y., and their colleagues compared the prevalence and incidence of different HPV types among HIV-positive women with varying levels of T cells, an indicator of immune status.

The final analysis included 2,058 HIV-positive women from the Women’s Interagency Human Immunodeficiency Virus Study and 871 HIV-positive women from a separate HIV Epidemiology Research Study. The women were examined during repeat study visits where cervical tissue samples were collected and HPV-type analysis was performed.

The researchers found that the prevalence ratio for HPV16, calculated by comparing prevalence rates of each HPV type for women with low versus high T-cell count, was low compared with that of other HPV types at every visit in both cohorts, suggesting that HPV16 is less influenced by the immune system than other HPV types.

In fact, the summary prevalence ratio for HPV16 was statistically significantly lower than that of all other HPV types combined. The incidence of HPV16 was also less associated with T-cell count than the incidence of other HPV types.

"The predominance of HPV16 in cervical disease in the general population might be explained partly by its ability to avoid immune clearance and the effects that this avoidance might have on the frequency and duration of infection," the authors write.

They say that the results of this study raise a number of testable hypotheses. "If it is true that the major etiologic risk factor for cervical cancer, HPV16, is not strongly affected by immune status, this fact could also help explain why cervical cancer rates appear to be only moderately increased in HIV/AIDS-affected women compared with HIV-seronegative women," they write.

Similarly, the use of highly active antiretroviral therapy (HAART) to improve immune status might only have a moderate effect on lowering an HIV-positive woman’s risk of developing precancerous lesions and cervical cancer. "We predict that the use of HAART in HIV-seropositive women will reduce the incidence, duration, and progression of cervical lesions, but that its effect will be less on lesions related to HPV16 than on those related to other HPV types," the authors say.

They add that additional studies should be able to address these predictions.

Contact:
Karen Gardner
Albert Einstein College of Medicine
Fon 001 - 718-430-3101
Email: kgardner@aecom.yu.edu

Linda Wang | EurekAlert!

More articles from Health and Medicine:

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

nachricht Chronic stress induces fatal organ dysfunctions via a new neural circuit
21.08.2017 | Hokkaido University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Stretchable biofuel cells extract energy from sweat to power wearable devices

22.08.2017 | Power and Electrical Engineering

New technique to treating mitral valve diseases: First patient data

22.08.2017 | Medical Engineering

IVAM Marketing Prize recognizes convincing technology marketing for the tenth time

22.08.2017 | Awards Funding

VideoLinks
B2B-VideoLinks
More VideoLinks >>>